What is the price target for ICUI stock?
12 analysts have analysed ICUI and the average price target is 187.27 USD. This implies a price increase of 43.45% is expected in the next year compared to the current price of 130.55.
NASDAQ:ICUI • US44930G1076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ICU MEDICAL INC (ICUI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-02-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-07 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-11-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-21 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-09-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-15 | Piper Sandler | Initiate | Overweight |
| 2025-08-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-05-09 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-04-21 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-08 | Needham | Reiterate | Hold -> Hold |
| 2024-12-11 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-13 | Needham | Reiterate | Hold |
| 2024-11-13 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-10-15 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-10-14 | Jefferies | Initiate | Hold |
| 2024-10-10 | Needham | Reiterate | Hold |
| 2024-09-12 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-08-08 | Needham | Reiterate | Hold |
| 2024-08-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-06-21 | Needham | Initiate | Hold |
| 2024-06-17 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2024-02-28 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-02-06 | Keybanc | Initiate | Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.259B -0.92% | 2.382B 5.44% | 2.231B -6.33% | 2.22B -0.50% | 2.319B 4.46% | 2.475B 6.73% | 2.637B 6.55% | 2.803B 6.30% | |
| EBITDA YoY % growth | 292.857M 11.06% | 322.316M 10.06% | 310.075M -3.80% | 426.3M 37.48% | 463.72M 8.78% | 510.31M 10.05% | 555.18M 8.79% | 589.76M 6.23% | |
| EBIT YoY % growth | 64.083M 124.85% | 102.804M 60.42% | 109.334M 6.35% | 356.1M 225.70% | 392.41M 10.20% | 441.46M 12.50% | N/A | N/A | |
| Operating Margin | 2.84% | 4.32% | 4.90% | 16.04% | 16.92% | 17.84% | N/A | N/A | |
| EPS YoY % growth | 6.76 3.36% | 6.22 -7.99% | 7.76 24.76% | 8.27 6.62% | 9.39 13.45% | 10.29 9.59% | 11.23 9.17% | 12.07 7.45% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.80 4.37% | 1.96 -6.63% | 2.06 1.61% | 2.26 18.18% | 2.13 18.69% | 2.28 16.13% | 2.35 13.99% | 2.54 12.70% |
| Revenue Q2Q % growth | 532.75M -11.13% | 542.9M -0.12% | 559.47M 4.91% | 560.49M 4.58% | 557.33M 4.61% | 564.06M 3.90% | 581.2M 3.88% | 581.2M 3.69% |
| EBITDA Q2Q % growth | 98.056M 24.07% | 102.92M -18.26% | 107.66M -39.10% | 110.62M -51.23% | 111.69M 13.90% | 113.93M 10.70% | 118.93M 10.47% | 121.38M 9.73% |
| EBIT Q2Q % growth | 79.305M 168.06% | 84.66M 215.84% | 87.465M 225.67% | 91.035M 248.97% | 85.272M 7.52% | 88.026M 3.98% | 93.534M 6.94% | 96.492M 5.99% |
All data in USD
12 analysts have analysed ICUI and the average price target is 187.27 USD. This implies a price increase of 43.45% is expected in the next year compared to the current price of 130.55.
ICU MEDICAL INC (ICUI) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of ICU MEDICAL INC (ICUI) is 1.8 USD and the consensus revenue estimate is 532.75M USD.
The consensus rating for ICU MEDICAL INC (ICUI) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.